Chattem Exiting Ephedra Market With Dexatrim Reformulations
This article was originally published in The Tan Sheet
Executive Summary
Chattem is getting out of the ephedra business and is set to ship three reformulated Dexatrim SKUs by the end of September
You may also be interested in...
Health & Nutrition Systems
West Palm Beach, Fla.-based firm will discontinue sales of ephedra products because supplier Garden State Nutritionals lost product liability insurance, HNS says Dec. 19. GSN reported in September plans to phase in ephedra-free offerings, but said it still intended to sell the botanical (1"The Tan Sheet" Sept. 9, 2002, p. 4). HNS expects an 18% drop in quarterly sales due to the announcement, noting 19% of 2002 sales came from ephedra-based products, such as Thin Tabs, Fat Cutter Plus. Company retains $10 mil. of liability insurance. Plans to release clinically-tested-for-safety ephedra product with single-dose packaging have been shelved, but firm may launch "after dust settles" on the ingredient...
Health & Nutrition Systems
West Palm Beach, Fla.-based firm will discontinue sales of ephedra products because supplier Garden State Nutritionals lost product liability insurance, HNS says Dec. 19. GSN reported in September plans to phase in ephedra-free offerings, but said it still intended to sell the botanical (1"The Tan Sheet" Sept. 9, 2002, p. 4). HNS expects an 18% drop in quarterly sales due to the announcement, noting 19% of 2002 sales came from ephedra-based products, such as Thin Tabs, Fat Cutter Plus. Company retains $10 mil. of liability insurance. Plans to release clinically-tested-for-safety ephedra product with single-dose packaging have been shelved, but firm may launch "after dust settles" on the ingredient...
Health & Nutrition Systems
West Palm Beach, Fla.-based firm will discontinue sales of ephedra products because supplier Garden State Nutritionals lost product liability insurance, HNS says Dec. 19. GSN reported in September plans to phase in ephedra-free offerings, but said it still intended to sell the botanical (1"The Tan Sheet" Sept. 9, 2002, p. 4). HNS expects an 18% drop in quarterly sales due to the announcement, noting 19% of 2002 sales came from ephedra-based products, such as Thin Tabs, Fat Cutter Plus. Company retains $10 mil. of liability insurance. Plans to release clinically-tested-for-safety ephedra product with single-dose packaging have been shelved, but firm may launch "after dust settles" on the ingredient...